SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 128 filers reported holding SAGENT PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,977,000 | -3.3% | 131,984 | -21.4% | 0.00% | 0.0% |
| Q1 2016 | $2,044,000 | +10.4% | 167,978 | +44.4% | 0.00% | 0.0% |
| Q4 2015 | $1,851,000 | -15.2% | 116,356 | -18.3% | 0.00% | 0.0% |
| Q3 2015 | $2,182,000 | -63.6% | 142,333 | -42.3% | 0.00% | -50.0% |
| Q2 2015 | $5,995,000 | +32.2% | 246,597 | +26.4% | 0.00% | +100.0% |
| Q1 2015 | $4,535,000 | +48.3% | 195,058 | +60.1% | 0.00% | 0.0% |
| Q4 2014 | $3,059,000 | +1196.2% | 121,832 | +1506.0% | 0.00% | – |
| Q3 2014 | $236,000 | -95.1% | 7,586 | -96.0% | 0.00% | -100.0% |
| Q2 2014 | $4,848,000 | -59.0% | 187,435 | -62.9% | 0.00% | -50.0% |
| Q1 2014 | $11,810,000 | -16.3% | 505,339 | -9.1% | 0.00% | -20.0% |
| Q4 2013 | $14,109,000 | +30.2% | 555,912 | +4.7% | 0.01% | +25.0% |
| Q3 2013 | $10,833,000 | +22.6% | 531,048 | +26.1% | 0.00% | +33.3% |
| Q2 2013 | $8,838,000 | +17.4% | 421,280 | -10.0% | 0.00% | 0.0% |
| Q4 2012 | $7,531,000 | +5.9% | 468,080 | +5.0% | 0.00% | 0.0% |
| Q3 2012 | $7,113,000 | -11.3% | 445,979 | +0.6% | 0.00% | -25.0% |
| Q2 2012 | $8,015,000 | +5.7% | 443,290 | +4.5% | 0.00% | 0.0% |
| Q1 2012 | $7,583,000 | – | 424,336 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|